6463-47-4 Usage
Derivative of pyrazole
The compound is based on a pyrazole ring, which is a five-membered ring with two nitrogen atoms.
Contains an amine group
The compound has a nitrogen atom with two hydrogen atoms attached, which is characteristic of an amine group.
Contains a fluorophenyl substituent
The compound has a phenyl ring (a six-membered carbon ring with hydrogen atoms) with one fluorine atom attached, which replaces one of the hydrogen atoms on the phenyl ring.
Potential applications in medicinal chemistry and pharmaceutical research
The compound has potential uses in the development of new drugs and other biologically active compounds.
Acts as a building block or intermediate in the synthesis of biologically active compounds
The compound can be used as a starting material or an intermediate step in the synthesis of other compounds with biological activity.
May exhibit biological activity or pharmacological effects
The compound may have effects on living organisms or pharmacological activity, but further research is needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 6463-47-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,4,6 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6463-47:
(6*6)+(5*4)+(4*6)+(3*3)+(2*4)+(1*7)=104
104 % 10 = 4
So 6463-47-4 is a valid CAS Registry Number.
6463-47-4Relevant academic research and scientific papers
Pharmaceutical formulations
-
, (2008/06/13)
Heterocyclic compounds of formula (I) STR1 and their acid addition salts, when administered topically, exhibit anti-inflammatory activity and do not produce the side-effects associated with the administration of certain other anti-inflammatories. The compounds of formula (I) may be administered topically as the compound alone or in a suitable topical pharmaceutical formulation.
3-Trifluoroacetylamino-1-aryl-2-pyrazolines
-
, (2008/06/13)
This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C4 and C5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
Therapeutically active 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs
-
, (2008/06/13)
A method of meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, treating pain or treating bacterial and fungal infections in mammals using 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs.
